2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Abscess | D000038 | 13 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shah MH and Paradkar A | Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme. | 2005 | Int J Pharm | pmid:15814241 |
| Kumar M K et al. | Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices. | 2004 | Int J Pharm | pmid:15019078 |
| Herai H et al. | Doxorubicin skin penetration from monoolein-containing propylene glycol formulations. | 2007 | Int J Pharm | pmid:17027205 |
| Wörle G et al. | Influence of composition and preparation parameters on the properties of aqueous monoolein dispersions. | 2007 | Int J Pharm | pmid:16987623 |
| Boyd BJ et al. | Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. | 2006 | Int J Pharm | pmid:16413980 |
| Sato H et al. | Development of cyclosporine A-loaded dry-emulsion formulation using highly purified glycerol monooleate for safe inhalation therapy. | 2013 | Int J Pharm | pmid:23528280 |
| Evenbratt H et al. | In vivo study of an instantly formed lipid-water cubic phase formulation for efficient topical delivery of aminolevulinic acid and methyl-aminolevulinate. | 2013 | Int J Pharm | pmid:23727140 |
| Li J et al. | A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. | 2013 | Int J Pharm | pmid:23916822 |
| Siekmann B et al. | Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases. | 2002 | Int J Pharm | pmid:12204563 |
| Gonçalves VSS et al. | Supercritical fluid precipitation of ketoprofen in novel structured lipid carriers for enhanced mucosal delivery--a comparison with solid lipid particles. | 2015 | Int J Pharm | pmid:26277371 |
| Mohamed AI et al. | In-vivo evaluation of clindamycin release from glyceryl monooleate-alginate microspheres by NIR spectroscopy. | 2015 | Int J Pharm | pmid:26276253 |
| Luo Q et al. | A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake. | 2015 | Int J Pharm | pmid:26209071 |
| Réeff J et al. | Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis. | 2015 | Int J Pharm | pmid:25934426 |
| Li Y et al. | Improving oral bioavailability of metformin hydrochloride using water-in-oil microemulsions and analysis of phase behavior after dilution. | 2014 | Int J Pharm | pmid:25014370 |
| Wang L et al. | In vitro and in vivo evaluation of chitosan graft glyceryl monooleate as peroral delivery carrier of enoxaparin. | 2014 | Int J Pharm | pmid:24882036 |
| Du LR et al. | Development and evaluation of liquid embolic agents based on liquid crystalline material of glyceryl monooleate. | 2014 | Int J Pharm | pmid:24858389 |
| Dong W et al. | Chitosan based polymer-lipid hybrid nanoparticles for oral delivery of enoxaparin. | 2018 | Int J Pharm | pmid:29859924 |
| Lee KW et al. | Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. | 2009 | Int J Pharm | pmid:18790030 |
| Libster D et al. | Molecular interactions in reverse hexagonal mesophase in the presence of Cyclosporin A. | 2009 | Int J Pharm | pmid:18977286 |
| Valente F et al. | Evaluation of toxicity of glycerol monooleate nanoparticles on PC12 cell line. | 2018 | Int J Pharm | pmid:29366940 |